speb/financial-data huggingface dataset:
Financial ratios for MACI — quarterly report dated 2024-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 10.06
Shares outstanding: 21621621
Market cap (USD): 217513507.26000002
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for MACI — quarterly report dated 2025-03-31
Total revenue: 0
Operating income: -156948
Net income: 1579993
Capital expenditures: 0
Operating cash flow: -185142
Net tangible assets: 160460357
Owner earnings: 1579993
Return on net tangible assets (%): 0.9846625232174947
Buffett classification: The Gruesome
Stock price: 10.23
P/E ratio: 34.99844347886352
Shares outstanding: 21621621
Book value: 160460357
P/B ratio: 1.378466226583305
Market cap (USD): 221189182.83
Debt to equity: 0
Current ratio: 27.906048239736876
Quick ratio: 27.906048239736876
Free cash flow (dilution-adjusted): -185142
Buyback yield (%): 0
Retained earnings: -5683955
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -0.09394688411925278
Rule of 40 score: 0
Financial ratios for MACI — quarterly report dated 2025-06-30
Total revenue: 0
Operating income: -233288
Net income: 1556238
Capital expenditures: 0
Operating cash flow: -137307
Net tangible assets: 162016595
Owner earnings: 1556238
Return on net tangible assets (%): 0.9605423444431725
Buffett classification: The Gruesome
Stock price: 10.51
P/E ratio: 72.45742954202034
Shares outstanding: 21621621
Book value: 162016595
P/B ratio: 1.40259234993798
Market cap (USD): 227243236.71
Debt to equity: 0.0014084236247527606
Current ratio: 3.3509055139700035
Quick ratio: 3.3509055139700035
Interest coverage ratio: -2140.256880733945
Free cash flow (dilution-adjusted): -137307
Buyback yield (%): 0
Retained earnings: -5914643
Receivables turnover: 0
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -0.13835411633119504
Rule of 40 score: 0
Financial ratios for MACI — quarterly report dated 2025-09-30
Total revenue: 0
Operating income: -712021
Net income: 1109702
Capital expenditures: 0
Operating cash flow: -215136
Net tangible assets: 163126297
Owner earnings: 1109702
Return on net tangible assets (%): 0.6802716793111536
Buffett classification: The Gruesome
Stock price: 10.5
P/E ratio: 53.46928943532553
Shares outstanding: 21621621
Book value: 163126297
P/B ratio: 1.391725458587465
Market cap (USD): 227027020.5
Debt to equity: 0.021835774277399307
Current ratio: 0.9957105244046396
Quick ratio: 0.9957105244046396
Interest coverage ratio: -1.8551827639844607
Free cash flow (dilution-adjusted): -215136
Buyback yield (%): 0
Retained earnings: -6617986
Receivables turnover: 0
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -0.4195113029538375
Rule of 40 score: 0
Financial ratios for MACI — annual report dated 2025-12-31
Total revenue: 0
Operating income: -1475992
Net income: 5539430
Capital expenditures: 0
Operating cash flow: -774258
Net tangible assets: 164419794
Owner earnings: 5539430
Return on net tangible assets (%): 3.369077326541353
Buffett classification: The Gruesome
Stock price: 10.63
P/E ratio: 41.49124210072156
Shares outstanding: 21621621
Book value: 164419794
P/B ratio: 1.3978720301157903
Market cap (USD): 229837831.23000002
Debt to equity: 0.022612916058026445
Current ratio: 0.9100848620200551
Quick ratio: 0.9100848620200551
Interest coverage ratio: -2.73366275753243
Free cash flow (dilution-adjusted): -774258
Buyback yield (%): 0
Retained earnings: -6986745
Receivables turnover: 0
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -0.8630533141678325
Rule of 40 score: 0
Financial ratios for MACI — quarterly report dated 2025-12-31
Total revenue: 0
Operating income: -373735
Net income: 1293497
Capital expenditures: 0
Operating cash flow: -236673
Net tangible assets: 164419794
Owner earnings: 1293497
Return on net tangible assets (%): 0.7867039414974575
Buffett classification: The Gruesome
Stock price: 10.63
P/E ratio: 41.49124210072156
Shares outstanding: 21621621
Book value: 164419794
P/B ratio: 1.3978720301157903
Market cap (USD): 229837831.23000002
Debt to equity: 0.022612916058026445
Current ratio: 0.9100848620200551
Quick ratio: 0.9100848620200551
Interest coverage ratio: -2.3953993667559703
Free cash flow (dilution-adjusted): -236673
Buyback yield (%): 0
Retained earnings: -6986745
Receivables turnover: 0
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -0.2185331833577112
Rule of 40 score: 0
Financial ratios for MDXG — annual report dated 2021-12-31
Capital expenditures: 0
Depreciation & amortization: 4363000
Buffett classification: The Gruesome
Stock price: 6.04
Shares outstanding: 148945731
Market cap (USD): 899632215.24
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for MDXG — annual report dated 2022-12-31
Total revenue: 267841000
Gross profit: 219525000
Operating income: -14727000
Net income: -30197000
Capital expenditures: 1514000
Operating cash flow: -17893000
Depreciation & amortization: 4046000
Net tangible assets: -43281000
Owner earnings: -27665000
Buffett classification: The Gruesome
Stock price: 2.78
Shares outstanding: 148945731
Book value: -17988000
Market cap (USD): 414069132.17999995
Debt to equity: -2.701467645096731
Current ratio: 3.080974355442294
Quick ratio: 2.7783134742980464
Interest coverage ratio: -2.936004784688995
COGS to revenue (%): 18.039060487378705
R&D to revenue (%): 4.741992450745031
SG&A to revenue (%): 77.90928199939516
Free cash flow (dilution-adjusted): -30735000
Buyback yield (%): 0.28739162316564454
Retained earnings: -191906000
Inventory turnover: 3.665023135856785
Receivables turnover: 6.2167161823414725
Capitalized R&D asset: 12701000
ROCI (R&D-adjusted, %): -4.452933449049374
FCF margin (%): -11.47509156551835
Rule of 40 score: -11.47509156551835
Financial ratios for MDXG — annual report dated 2023-12-31
Total revenue: 321477000
Gross profit: 266843000
Operating income: 37116000
Net income: 58228000
Capital expenditures: 1987000
Operating cash flow: 26775000
Depreciation & amortization: 3427000
Net tangible assets: 118019000
Owner earnings: 59668000
Return on net tangible assets (%): 50.55796100627865
Capex to operating income (%): 5.3534863670654165
Buffett classification: The Great
Stock price: 8.77
P/E ratio: 22.433435132067046
Shares outstanding: 148945731
Book value: 142717000
P/B ratio: 9.152757280982645
Market cap (USD): 1306254060.87
Debt to equity: 0.34403049391453017
Current ratio: 3.570270387758651
Quick ratio: 3.113371587549991
Effective tax rate (%): -120.15147063624197
Interest coverage ratio: 5.748180269474989
COGS to revenue (%): 16.99468391206836
R&D to revenue (%): 3.9396286515053953
SG&A to revenue (%): 65.67312747101658
Free cash flow (dilution-adjusted): 7829000
Buyback yield (%): 0.7284187881232504
Retained earnings: -133678000
Inventory turnover: 2.599020027591456
Receivables turnover: 5.9675335523751185
Capitalized R&D asset: 21174670
ROCI (R&D-adjusted, %): 19.291797141922203
Rosenberg metric: 3.725533422565152
FCF margin (%): 2.4353219670458537
Revenue growth (%): 20.02531352556181
Rule of 40 score: 22.460635492607665
Financial ratios for MDXG — quarterly report dated 2024-09-30
Capital expenditures: 5223000
Depreciation & amortization: 580000
Buffett classification: The Gruesome
Stock price: 5.91
Shares outstanding: 148945731
Market cap (USD): 880269270.21
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for MDXG — annual report dated 2024-12-31
Total revenue: 348879000
Gross profit: 288806000
Operating income: 59311000
Net income: 42419000
Capital expenditures: 1683000
Operating cash flow: 66198000
Depreciation & amortization: 6041000
Net tangible assets: 162040000
Owner earnings: 46777000
Return on net tangible assets (%): 28.86756356455196
Capex to operating income (%): 2.837584933654803
Buffett classification: The Great
Stock price: 9.62
P/E ratio: 33.77868248237817
Shares outstanding: 148945731
Book value: 193107000
P/B ratio: 7.420020673616181
Market cap (USD): 1432857932.2199998
Debt to equity: 0.09751070649950545
Current ratio: 4.208487772782103
Quick ratio: 3.686347187191578
Effective tax rate (%): 26.697385415575802
Interest coverage ratio: 58.9572564612326
COGS to revenue (%): 17.218863846777825
R&D to revenue (%): 3.5373295612518953
SG&A to revenue (%): 64.5172108381416
Free cash flow (dilution-adjusted): 47582000
Buyback yield (%): 0.18431694731299453
Retained earnings: -91259000
Inventory turnover: 2.523333473348175
Receivables turnover: 6.249176040696424
Capitalized R&D asset: 25017880
ROCI (R&D-adjusted, %): 24.28023125704884
Rosenberg metric: 1.7341492301618635
FCF margin (%): 13.638539436308864
Revenue growth (%): 8.523782416782538
Rule of 40 score: 22.162321853091402
Financial ratios for MDXG — quarterly report dated 2024-12-31
Capital expenditures: 0
Depreciation & amortization: 564000
Buffett classification: The Gruesome
Stock price: 9.62
Shares outstanding: 148945731
Market cap (USD): 1432857932.2199998
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for MDXG — quarterly report dated 2025-03-31
Total revenue: 88205000
Gross profit: 71647000
Operating income: 8251000
Net income: 7023000
Capital expenditures: 377000
Operating cash flow: 5299000
Depreciation & amortization: 3203000
Net tangible assets: 172273000
Owner earnings: 9849000
Return on net tangible assets (%): 5.717088574529961
Capex to operating income (%): 4.5691431341655555
Buffett classification: The Great
Stock price: 7.6
P/E ratio: 40.2957267407091
Shares outstanding: 148945731
Book value: 202776000
P/B ratio: 5.582453325837378
Market cap (USD): 1131987555.6
Debt to equity: 0.09201286148262122
Current ratio: 4.695370609352636
Quick ratio: 4.1305990286022665
Effective tax rate (%): 18.450998606595448
Interest coverage ratio: 17.261506276150627
COGS to revenue (%): 18.77217844793379
R&D to revenue (%): 3.7730287398673545
SG&A to revenue (%): 67.98820928518792
Free cash flow (dilution-adjusted): 660000
Buyback yield (%): 0.21714019627160644
Retained earnings: -84236000
Inventory turnover: 0.6879102617366015
Receivables turnover: 1.4160833547392757
Capitalized R&D asset: 3328000
ROCI (R&D-adjusted, %): 4.529793607321741
FCF margin (%): 0.7482569015361941
Rule of 40 score: 0.7482569015361941
Financial ratios for MDXG — quarterly report dated 2025-06-30
Total revenue: 98605000
Gross profit: 79924000
Operating income: 12370000
Net income: 9618000
Capital expenditures: 179000
Operating cash flow: 14419000
Depreciation & amortization: 3168000
Net tangible assets: 185155000
Owner earnings: 12607000
Return on net tangible assets (%): 6.808889849045395
Capex to operating income (%): 1.4470493128536783
Buffett classification: The Great
Stock price: 6.11
P/E ratio: 54.68772407968272
Shares outstanding: 148945731
Book value: 216624000
P/B ratio: 4.201096907129404
Market cap (USD): 910058416.4100001
Debt to equity: 0.08522139744441982
Current ratio: 4.392046132431895
Quick ratio: 3.8971167230065618
Effective tax rate (%): 26.055201045590838
COGS to revenue (%): 18.9452867501648
R&D to revenue (%): 3.3497287155823745
SG&A to revenue (%): 65.05856700978651
Free cash flow (dilution-adjusted): 9451000
Buyback yield (%): 0.05779848749434851
Retained earnings: -74620000
Inventory turnover: 0.7505423865006027
Receivables turnover: 1.4243514185011845
Capitalized R&D asset: 5532760
ROCI (R&D-adjusted, %): 5.464814485866334
Rosenberg metric: 2.487079326923077
FCF margin (%): 9.58470665787739
Revenue growth (%): 11.790714812085483
Rule of 40 score: 21.375421469962873
Financial ratios for MDXG — quarterly report dated 2025-09-30
Total revenue: 113725000
Gross profit: 95006000
Operating income: 22190000
Net income: 16748000
Capital expenditures: 192000
Operating cash flow: 29329000
Depreciation & amortization: 5290000
Net tangible assets: 208358000
Owner earnings: 21846000
Return on net tangible assets (%): 10.48483859511034
Capex to operating income (%): 0.8652546191978367
Buffett classification: The Great
Stock price: 6.98
P/E ratio: 31.137236885800718
Shares outstanding: 148945731
Book value: 238946000
P/B ratio: 4.350946248859575
Market cap (USD): 1039641202.3800001
Debt to equity: 0.07622642772844074
Current ratio: 4.405100377934191
Quick ratio: 3.945650289518394
Effective tax rate (%): 26.701387369250295
COGS to revenue (%): 16.45988129259178
R&D to revenue (%): 3.256100241811387
SG&A to revenue (%): 60.67355462739064
Free cash flow (dilution-adjusted): 20491000
Buyback yield (%): 0.007983523528116444
Retained earnings: -57872000
Inventory turnover: 0.7063240510150177
Receivables turnover: 1.4545442918169493
Capitalized R&D asset: 7014250
ROCI (R&D-adjusted, %): 8.366246428785502
Rosenberg metric: 4.5661519830457165
FCF margin (%): 18.018025939766982
Revenue growth (%): 15.333908016834846
Rule of 40 score: 33.351933956601826
Financial ratios for MDXG — annual report dated 2025-12-31
Total revenue: 418630000
Gross profit: 345617000
Operating income: 63887000
Net income: 48578000
Capital expenditures: 1033000
Operating cash flow: 74003000
Depreciation & amortization: 14881000
Net tangible assets: 222949000
Owner earnings: 62426000
Return on net tangible assets (%): 28.00012558926032
Capex to operating income (%): 1.6169173697309314
Buffett classification: The Great
Stock price: 6.77
P/E ratio: 20.75759806640866
Shares outstanding: 148945731
Book value: 256548000
P/B ratio: 3.930502669558913
Market cap (USD): 1008362598.8699999
Debt to equity: 0.0700336779082277
Current ratio: 4.317539601033205
Quick ratio: 3.9232409049886408
Effective tax rate (%): 26.687996136548854
COGS to revenue (%): 17.440938298736356
R&D to revenue (%): 3.606287174832191
SG&A to revenue (%): 63.58693834651123
Free cash flow (dilution-adjusted): 56574000
Buyback yield (%): 0.3092141659651122
Retained earnings: -42681000
Inventory turnover: 2.8813338595106552
Receivables turnover: 5.529607566011069
Capitalized R&D asset: 27544920
ROCI (R&D-adjusted, %): 21.44801802091568
Rosenberg metric: 4.603435702131108
FCF margin (%): 13.514081647278026
Revenue growth (%): 19.99289151826278
Rule of 40 score: 33.506973165540806
Financial ratios for MDXG — quarterly report dated 2025-12-31
Total revenue: 118095000
Gross profit: 99040000
Operating income: 21077000
Net income: 15191000
Capital expenditures: 285000
Operating cash flow: 24956000
Depreciation & amortization: 3220000
Net tangible assets: 222949000
Owner earnings: 18126000
Return on net tangible assets (%): 8.130110473695778
Capex to operating income (%): 1.3521848460407078
Buffett classification: The Great
Stock price: 6.77
P/E ratio: 20.75674349258954
Shares outstanding: 148945731
Book value: 256548000
P/B ratio: 3.930502669558913
Market cap (USD): 1008362598.8699999
Debt to equity: 0.0700336779082277
Current ratio: 4.317539601033205
Quick ratio: 3.9232409049886408
Effective tax rate (%): 30.300527643955032
COGS to revenue (%): 16.13531478894111
R&D to revenue (%): 4.031500063508193
SG&A to revenue (%): 61.876455396079436
Free cash flow (dilution-adjusted): 25972000
Buyback yield (%): 0.005057704446510815
Retained earnings: -42681000
Inventory turnover: 0.7519731649565904
Receivables turnover: 1.5598953861598004
Capitalized R&D asset: 8332000
ROCI (R&D-adjusted, %): 7.643604597765292
Rosenberg metric: 1.0893869835268701
FCF margin (%): 21.992463694483256
Revenue growth (%): 3.8426027698395253
Rule of 40 score: 25.835066464322782
Financial ratios for MKLY — quarterly report dated 2025-12-31
Total revenue: 0
Operating income: -179247
Net income: 1483714
Capital expenditures: 0
Operating cash flow: -250831
Owner earnings: 1483714
Buffett classification: The Gruesome
Stock price: 9.97
P/E ratio: 87.3709583566556
Shares outstanding: 17801250
Market cap (USD): 177478462.5
Free cash flow (dilution-adjusted): -250831
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for MKLY — annual report dated 2025-12-31
Capital expenditures: 0
Net tangible assets: 172334707
Buffett classification: The Gruesome
Stock price: 9.97
Shares outstanding: 17801250
Book value: 172334707
P/B ratio: 1.029847472917919
Market cap (USD): 177478462.5
Debt to equity: 0
Current ratio: 19.954985689753865
Quick ratio: 19.954985689753865
Buyback yield (%): 0
Retained earnings: -2303752
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for MLEC — annual report dated 2021-06-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 1465.5
Shares outstanding: 726118
Market cap (USD): 1064125929
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for MLEC — annual report dated 2022-06-30
Total revenue: 0
Gross profit: 0
Operating income: -3652433
Net income: -4526905
Capital expenditures: 0
Operating cash flow: -1885979
Depreciation & amortization: 1699
Net tangible assets: -2994597
Owner earnings: -4525206
Buffett classification: The Gruesome
Stock price: 1498.5
Shares outstanding: 726118
Book value: 1604333
P/B ratio: 678.2181897399107
Market cap (USD): 1088087823
Debt to equity: 0
Current ratio: 0.26517425326321187
Quick ratio: 0.26517425326321187
Interest coverage ratio: -1714.7572769953051
Free cash flow (dilution-adjusted): -2724555
Buyback yield (%): 0
Retained earnings: -6834243
Capitalized R&D asset: 985158
ROCI (R&D-adjusted, %): -115.685321941648
Rule of 40 score: 0
Financial ratios for MLEC — annual report dated 2023-06-30
Total revenue: 420867429
Gross profit: 179217672
Operating income: 50608111
Net income: 53122608
Capital expenditures: 11354542
Operating cash flow: -41158857
Depreciation & amortization: 19509405
Net tangible assets: 1335395
Owner earnings: 61277471
Return on net tangible assets (%): 4588.715024393532
Capex to operating income (%): 22.436209879479595
Buffett classification: The Great
Stock price: 552
P/E ratio: 7.545132874500439
Shares outstanding: 726118
Book value: 10105933
P/B ratio: 39.66156672520983
Market cap (USD): 400817136
Debt to equity: 0.261756039744178
Current ratio: 0.42318875870680905
Quick ratio: 0.38622225823864403
Effective tax rate (%): -4.583917208568641
Interest coverage ratio: 1.6555111277987802
COGS to revenue (%): 57.41707253853564
R&D to revenue (%): 3.7883632472780397
SG&A to revenue (%): 21.05300194185376
Free cash flow (dilution-adjusted): -67572268
Buyback yield (%): 0.7477092995345389
Retained earnings: -58623123
Inventory turnover: 518.8422859572129
Receivables turnover: 248.84638976298342
Capitalized R&D asset: 16604042.86
ROCI (R&D-adjusted, %): 217.09703401691098
Rosenberg metric: 181.9176944205904
FCF margin (%): -16.05547574934814
Rule of 40 score: -16.05547574934814
Financial ratios for MLEC — annual report dated 2024-06-30
Total revenue: 466376330
Gross profit: 179311632
Operating income: 41764825
Net income: -29061304
Capital expenditures: 9599885
Operating cash flow: 39557562
Depreciation & amortization: 21332177
Net tangible assets: -288281876
Owner earnings: -17329012
Capex to operating income (%): 22.985574583396435
Buffett classification: The Great
Stock price: 165
Shares outstanding: 726118
Book value: 250001370
P/B ratio: 0.4792352537908092
Market cap (USD): 119809470
Debt to equity: 1.8154015675994095
Current ratio: 1.0252763427057714
Quick ratio: 0.7299490520955016
Interest coverage ratio: 1.1671400778802736
COGS to revenue (%): 61.5521585325739
R&D to revenue (%): 3.7357142460467494
SG&A to revenue (%): 20.153896961280175
Free cash flow (dilution-adjusted): 332389
Buyback yield (%): 0.612963232372199
Retained earnings: 1142761
Inventory turnover: 2.2742499118748523
Receivables turnover: 1.9671406805245095
Capitalized R&D asset: 28430060.43
ROCI (R&D-adjusted, %): 8.665807700524043
Rosenberg metric: 0.005893130745778958
FCF margin (%): 0.07127055526167034
Revenue growth (%): 10.813120204652378
Rule of 40 score: 10.884390759914048
Financial ratios for MLEC — quarterly report dated 2024-09-30
Total revenue: 1557002
Gross profit: 14773
Operating income: -2101455
Net income: -1915499
Capital expenditures: 59738
Operating cash flow: -1126149
Depreciation & amortization: 324607
Net tangible assets: -3536894
Owner earnings: -1650630
Buffett classification: The Gruesome
Stock price: 131.85
Shares outstanding: 726118
Book value: 5693163
P/B ratio: 16.816426703398445
Market cap (USD): 95738658.3
Debt to equity: 3.8789750091469366
Current ratio: 1.514741677559543
Quick ratio: 0.7572695944454818
Interest coverage ratio: -3.8196466546703745
COGS to revenue (%): 99.05118940116968
R&D to revenue (%): 27.33085763537876
SG&A to revenue (%): 103.69935298734363
Free cash flow (dilution-adjusted): -1471447
Buyback yield (%): 0
Retained earnings: -67850882
Inventory turnover: 0.2765064810702762
Receivables turnover: 0.9599355358184349
Capitalized R&D asset: 425542
ROCI (R&D-adjusted, %): -7.094923757113553
FCF margin (%): -94.50514514432223
Rule of 40 score: -94.50514514432223
Financial ratios for MLEC — quarterly report dated 2024-12-31
Total revenue: 2642964
Gross profit: -674369
Operating income: -2059504
Net income: -2427307
Capital expenditures: 59738
Operating cash flow: -2153878
Depreciation & amortization: 147978
Net tangible assets: -6540311
Owner earnings: -2339067
Buffett classification: The Gruesome
Stock price: 120
Shares outstanding: 726118
Book value: 2796578
P/B ratio: 31.157421677492994
Market cap (USD): 87134160
Debt to equity: 7.897430001952386
Current ratio: 1.4779604379404936
Quick ratio: 0.727758090602985
Interest coverage ratio: -3.1015692298424744
COGS to revenue (%): 143.39650483320997
R&D to revenue (%): 11.275333300037381
SG&A to revenue (%): 34.035688719180435
Free cash flow (dilution-adjusted): -1808580
Buyback yield (%): 0
Retained earnings: -70278189
Inventory turnover: 0.7822694685592081
Receivables turnover: 0.9650778024700194
Capitalized R&D asset: 583116.14
ROCI (R&D-adjusted, %): -7.851648682801147
Rosenberg metric: -1.6194453191459361
FCF margin (%): -68.42998996581112
Revenue growth (%): 69.74698812204481
Rule of 40 score: 1.3169981562336943
Financial ratios for MLEC — annual report dated 2025-06-30
Total revenue: 333611248
Gross profit: 125741464
Operating income: -3509587
Net income: -46281816
Capital expenditures: 5261125
Operating cash flow: 3636413
Depreciation & amortization: 22253451
Net tangible assets: -141229873
Owner earnings: -29289490
Buffett classification: The Gruesome
Stock price: 94.5
Shares outstanding: 726118
Book value: -82873602
Market cap (USD): 68618151
Debt to equity: -2.97899563964892
Current ratio: 0.13214095820225208
Quick ratio: 0.12267069040142609
Interest coverage ratio: -0.09216848111999301
COGS to revenue (%): 62.30898545722895
R&D to revenue (%): 4.537769661771116
SG&A to revenue (%): 26.62574614390699
Free cash flow (dilution-adjusted): -15367072
Buyback yield (%): 1.3508073104447247
Retained earnings: -110317946
Inventory turnover: 92.9865612874539
Receivables turnover: 16.735412715173982
Capitalized R&D asset: 32073092
ROCI (R&D-adjusted, %): -621.8635611424063
Rosenberg metric: -3.074771586857835
FCF margin (%): -4.606281140736598
Revenue growth (%): -28.467371403690233
Rule of 40 score: -33.07365254442683
Financial ratios for NEXE.V — annual report dated 2022-05-31
Total revenue: 21248.818897637793
Gross profit: -23099.212598425198
Operating income: -6194725.196850394
Net income: -6566860.629921259
Capital expenditures: 6893334.645669291
Operating cash flow: -6475181.889763779
Depreciation & amortization: 529787.4015748032
Net tangible assets: 35207228.34645669
Owner earnings: -12930407.874015747
Return on net tangible assets (%): -36.72657144940261
Buffett classification: The Gruesome
Stock price: 0.28346456692913385
Shares outstanding: 97293297
Book value: 35269417.32283464
P/B ratio: 0.7819579792535123
Market cap (USD): 27579202.299212597
Debt to equity: 0.03952787719993857
Current ratio: 11.537894344934141
Quick ratio: 11.22912832694158
Interest coverage ratio: -25.446768251462803
COGS to revenue (%): 208.7082190765582
R&D to revenue (%): 1246.794634254799
SG&A to revenue (%): 22201.97509819907
Free cash flow (dilution-adjusted): -13861975.59055118
Buyback yield (%): 0
Retained earnings: -24731096.062992126
Inventory turnover: 0.06058298293905237
Receivables turnover: 0.02016253456493201
Capitalized R&D asset: 264929.13385826774
ROCI (R&D-adjusted, %): -16.438205974924163
FCF margin (%): -65236.45223449196
Rule of 40 score: -65236.45223449196
Financial ratios for NEXE.V — annual report dated 2023-05-31
Total revenue: 36586.76470588235
Gross profit: -119258.82352941176
Operating income: -4188828.676470588
Net income: -4512547.794117646
Capital expenditures: 2397522.7941176468
Operating cash flow: -2877992.647058823
Depreciation & amortization: 726140.4411764705
Net tangible assets: 28978976.470588233
Owner earnings: -6183930.147058822
Return on net tangible assets (%): -21.339367017793425
Buffett classification: The Gruesome
Stock price: 0.30882352941176466
Shares outstanding: 97293297
Book value: 29037049.999999996
P/B ratio: 1.0347628070911836
Market cap (USD): 30046459.367647056
Debt to equity: 0.024953135431335847
Current ratio: 8.187799739408636
Quick ratio: 7.94088754720564
Interest coverage ratio: -22.127045471317764
COGS to revenue (%): 425.9616544073315
R&D to revenue (%): 763.8751557538486
SG&A to revenue (%): 10384.209574339804
Free cash flow (dilution-adjusted): -5799995.5882352935
Buyback yield (%): 0
Retained earnings: -27607027.20588235
Inventory turnover: 0.2680875284593979
Receivables turnover: 0.02106238967833695
Capitalized R&D asset: 456979.7255673923
ROCI (R&D-adjusted, %): -13.643478978276125
Rosenberg metric: -0.3629635198310436
FCF margin (%): -15852.715141283812
Revenue growth (%): 72.18258051015559
Rule of 40 score: -15780.532560773656
Financial ratios for NEXE.V — annual report dated 2024-05-31
Total revenue: 108951.82481751824
Gross profit: -134517.51824817518
Operating income: -4996560.583941606
Net income: -4766859.124087591
Capital expenditures: 650713.1386861313
Operating cash flow: -1782666.4233576641
Depreciation & amortization: 1245626.2773722627
Net tangible assets: 24464297.080291968
Owner earnings: -4171945.9854014595
Return on net tangible assets (%): -17.053201944487135
Buffett classification: The Gruesome
Stock price: 0.2554744525547445
Shares outstanding: 97293297
Book value: 24521946.715328466
P/B ratio: 1.01362065894972
Market cap (USD): 24855951.788321164
Debt to equity: 0.019822940076291557
Current ratio: 5.899598850368516
Quick ratio: 5.6748535288572
Interest coverage ratio: -37.913950860712944
COGS to revenue (%): 223.4651355986708
R&D to revenue (%): 512.4490835030549
SG&A to revenue (%): 2868.3721459963554
Free cash flow (dilution-adjusted): -2897084.6715328465
Buyback yield (%): 0
Retained earnings: -32172375.18248175
Inventory turnover: 0.5664712495711807
Receivables turnover: 0.46228223670966445
Capitalized R&D asset: 832998.969851631
ROCI (R&D-adjusted, %): -18.807014993698875
Rosenberg metric: -0.054597278052030594
FCF margin (%): -2659.051077285883
Revenue growth (%): 197.7902684027188
Rule of 40 score: -2461.260808883164
Financial ratios for NEXE.V — quarterly report dated 2024-11-30
Total revenue: 50538.571428571435
Gross profit: -110925.71428571429
Operating income: -1198950.7142857143
Net income: -1175467.8571428573
Capital expenditures: 0
Operating cash flow: 0
Depreciation & amortization: 347700.7142857143
Net tangible assets: 24516622.142857146
Owner earnings: -827767.142857143
Return on net tangible assets (%): -3.3763506980439013
Buffett classification: The Gruesome
Stock price: 0.29285714285714287
Shares outstanding: 97293297
Book value: 24573036.42857143
P/B ratio: 1.1595244674541791
Market cap (USD): 28493036.97857143
Debt to equity: 0.013931065150358912
Current ratio: 6.1252196463801125
Quick ratio: 5.903992243714734
Interest coverage ratio: -57.49575255189422
COGS to revenue (%): 1007.4780224439608
R&D to revenue (%): 149.63252960963337
SG&A to revenue (%): 1315.2373010713175
Free cash flow (dilution-adjusted): 0
Buyback yield (%): 0
Retained earnings: -31020768.571428575
Inventory turnover: 1.1583251814273041
Receivables turnover: 0.19912698658396213
Capitalized R&D asset: 75622.14285714286
ROCI (R&D-adjusted, %): -4.654108810153742
FCF margin (%): 0
Rule of 40 score: 0
Financial ratios for NEXE.V — quarterly report dated 2025-02-28
Total revenue: 120639.58333333334
Gross profit: -61579.86111111112
Operating income: -1310338.1944444445
Net income: -1218653.4722222222
Capital expenditures: 31275
Operating cash flow: -1269590.2777777778
Depreciation & amortization: 566790.2777777778
Net tangible assets: 22704173.611111112
Owner earnings: -683138.1944444445
Return on net tangible assets (%): -3.0088661500990552
Buffett classification: The Gruesome
Stock price: 0.20833333333333334
Shares outstanding: 97293297
Book value: 22759020.833333332
P/B ratio: 0.890611112992742
Market cap (USD): 20269436.875
Debt to equity: 0.011541577378200768
Current ratio: 5.523294727626588
Quick ratio: 5.343249996756854
Interest coverage ratio: -78.64322927520527
COGS to revenue (%): 151.04449087905317
R&D to revenue (%): 58.28426039454067
SG&A to revenue (%): 800.0725300913533
Free cash flow (dilution-adjusted): -1450776.388888889
Buyback yield (%): 0
Retained earnings: -31377734.02777778
Inventory turnover: 0.5109772198832367
Receivables turnover: 0.4114008435421191
Capitalized R&D asset: 120980.7246031746
ROCI (R&D-adjusted, %): -5.632297035503879
Rosenberg metric: 0.6525318023296696
FCF margin (%): -1202.5707887935253
Revenue growth (%): 138.70794112935897
Rule of 40 score: -1063.8628476641663
Financial ratios for NEXE.V — quarterly report dated 2025-08-31
Total revenue: 87944.52554744524
Gross profit: 12009.48905109489
Operating income: -1088028.4671532847
Net income: -1042194.8905109488
Capital expenditures: 71281.75182481752
Operating cash flow: -554937.9562043796
Depreciation & amortization: 327829.92700729927
Net tangible assets: 21886545.98540146
Owner earnings: -785646.7153284671
Return on net tangible assets (%): -3.5896331739713574
Buffett classification: The Gruesome
Stock price: 0.145985401459854
Shares outstanding: 97293297
Book value: 21944195.620437954
P/B ratio: 0.64725092993016
Market cap (USD): 14203401.02189781
Debt to equity: 0.013618119857310255
Current ratio: 4.045703292265288
Quick ratio: 3.849833412279547
Interest coverage ratio: -114.6173779315648
COGS to revenue (%): 86.34424487898809
R&D to revenue (%): 85.87032303044388
SG&A to revenue (%): 792.1923242920224
Free cash flow (dilution-adjusted): -786059.8540145985
Buyback yield (%): 0
Retained earnings: -35291382.48175182
Inventory turnover: 0.1701020308054547
Receivables turnover: 0.3833663719179455
Capitalized R&D asset: 147583.86087359517
ROCI (R&D-adjusted, %): -4.917341824836468
Rosenberg metric: 1.0465834179431188
FCF margin (%): -893.8132864114739
Revenue growth (%): -27.10143460587889
Rule of 40 score: -920.9147210173528
Financial ratios for NEXE.V — quarterly report dated 2025-11-30
Total revenue: 141888.57142857145
Gross profit: -35202.857142857145
Operating income: -797295
Net income: -742871.4285714286
Capital expenditures: 9944.285714285716
Operating cash flow: -539945
Depreciation & amortization: 317307.1428571429
Net tangible assets: 20795185.714285716
Owner earnings: -435508.5714285715
Return on net tangible assets (%): -2.0942759416156074
Buffett classification: The Gruesome
Stock price: 0.10714285714285715
Shares outstanding: 97293297
Book value: 20851600.000000004
P/B ratio: 0.49992719126726826
Market cap (USD): 10424281.821428573
Debt to equity: 0.01139278794638575
Current ratio: 4.182551344089889
Quick ratio: 3.966984600019161
Interest coverage ratio: -164.48762157382845
COGS to revenue (%): 124.81021324580657
R&D to revenue (%): 7.919695535732265
SG&A to revenue (%): 346.7796661364048
Free cash flow (dilution-adjusted): -670397.142857143
Buyback yield (%): 0
Retained earnings: -35278009.28571429
Inventory turnover: 0.4036153600708486
Receivables turnover: 0.4450867570086758
Capitalized R&D asset: 85037.95246784846
ROCI (R&D-adjusted, %): -4.004531604771988
Rosenberg metric: -0.6251779845903179
FCF margin (%): -472.4814240550935
Revenue growth (%): 61.338719545452435
Rule of 40 score: -411.1427045096411
Financial ratios for OCUL — annual report dated 2021-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 6.97
Shares outstanding: 218960358
Market cap (USD): 1526153695.26
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for OCUL — annual report dated 2022-12-31
Total revenue: 51494000
Gross profit: 46954000
Operating income: -78654000
Net income: -71038000
Capital expenditures: 3715000
Operating cash flow: -59603000
Depreciation & amortization: 2109000
Net tangible assets: 35379000
Owner earnings: -72644000
Return on net tangible assets (%): -205.33084598207978
Buffett classification: The Gruesome
Stock price: 2.81
Shares outstanding: 218960358
Book value: 35379000
P/B ratio: 17.3910683167981
Market cap (USD): 615278605.98
Debt to equity: 1.8169818253766359
Current ratio: 4.128905876731964
Quick ratio: 4.066029622551362
Interest coverage ratio: -11.201082312731415
COGS to revenue (%): 8.81656115275566
R&D to revenue (%): 103.82180448207559
SG&A to revenue (%): 140.10564337592731
Free cash flow (dilution-adjusted): -80282000
Buyback yield (%): 0
Retained earnings: -616842000
Inventory turnover: 2.2998986828774064
Receivables turnover: 2.4147245017584993
Capitalized R&D asset: 53462000
ROCI (R&D-adjusted, %): -25.10134845973685
FCF margin (%): -155.90554239328853
Rule of 40 score: -155.90554239328853
Financial ratios for OCUL — annual report dated 2023-12-31
Total revenue: 58443000
Gross profit: 53162000
Operating income: -82382000
Net income: -80736000
Capital expenditures: 6087000
Operating cash flow: -70234000
Depreciation & amortization: 2983000
Net tangible assets: 91131000
Owner earnings: -83840000
Return on net tangible assets (%): -91.99942939285205
Buffett classification: The Gruesome
Stock price: 4.46
Shares outstanding: 218960358
Book value: 91131000
P/B ratio: 10.71603731639069
Market cap (USD): 976563196.68
Debt to equity: 0.9150453742414766
Current ratio: 6.655060751948647
Quick ratio: 6.589007336084365
Interest coverage ratio: -7.266008114305874
COGS to revenue (%): 9.036154885957258
R&D to revenue (%): 104.4693119791934
SG&A to revenue (%): 127.45581164553496
Free cash flow (dilution-adjusted): -94146000
Buyback yield (%): 0
Retained earnings: -697578000
Inventory turnover: 2.291106290672451
Receivables turnover: 2.232438213835517
Capitalized R&D asset: 96874540
ROCI (R&D-adjusted, %): -18.946506799239778
Rosenberg metric: 0.11611986083573379
FCF margin (%): -161.0902931061034
Revenue growth (%): 13.4947760904183
Rule of 40 score: -147.5955170156851
Financial ratios for OCUL — quarterly report dated 2024-09-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 8.7
Shares outstanding: 218960358
Market cap (USD): 1904955114.6
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for OCUL — quarterly report dated 2024-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 8.54
Shares outstanding: 218960358
Market cap (USD): 1869921457.3199997
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for OCUL — annual report dated 2024-12-31
Total revenue: 63723000
Gross profit: 58097000
Operating income: -171781000
Net income: -193506000
Capital expenditures: 1288000
Operating cash flow: -134677000
Depreciation & amortization: 3786000
Net tangible assets: 315344000
Owner earnings: -191008000
Return on net tangible assets (%): -60.57131259830534
Buffett classification: The Gruesome
Stock price: 8.54
Shares outstanding: 218960358
Book value: 315344000
P/B ratio: 5.9297828952508995
Market cap (USD): 1869921457.3199997
Debt to equity: 0.2403185093104673
Current ratio: 10.663708468346472
Quick ratio: 10.590196837065339
Interest coverage ratio: -12.652353244457538
COGS to revenue (%): 8.828837311488789
R&D to revenue (%): 200.2965962054517
SG&A to revenue (%): 160.44913139682689
Free cash flow (dilution-adjusted): -169074000
Buyback yield (%): 0
Retained earnings: -891084000
Inventory turnover: 1.8506578947368422
Receivables turnover: 1.9674879585031493
Capitalized R&D asset: 186184310
ROCI (R&D-adjusted, %): -20.715082845980856
Rosenberg metric: 0.08082876095323888
FCF margin (%): -265.32649121981075
Revenue growth (%): 9.034443817052512
Rule of 40 score: -256.2920474027582
Financial ratios for OCUL — quarterly report dated 2025-03-31
Total revenue: 10698000
Gross profit: 9436000
Operating income: -63917000
Net income: -64053000
Capital expenditures: 1933000
Operating cash flow: -44671000
Depreciation & amortization: 981000
Net tangible assets: 265930000
Owner earnings: -65005000
Return on net tangible assets (%): -24.444402662354754
Buffett classification: The Gruesome
Stock price: 7.33
Shares outstanding: 218960358
Book value: 265930000
P/B ratio: 6.035345482420186
Market cap (USD): 1604979424.14
Debt to equity: 0.2866318204038657
Current ratio: 10.222380425038232
Quick ratio: 10.136186257448715
Interest coverage ratio: -21.41990616621984
COGS to revenue (%): 11.796597494858851
R&D to revenue (%): 400.60759020377634
SG&A to revenue (%): 285.06262852869696
Free cash flow (dilution-adjusted): -57060000
Buyback yield (%): 0
Retained earnings: -955137000
Inventory turnover: 0.3860507800550627
Receivables turnover: 0.4241703342452718
Capitalized R&D asset: 42857000
ROCI (R&D-adjusted, %): -8.603037759836695
FCF margin (%): -533.3707234997196
Rule of 40 score: -533.3707234997196
Financial ratios for OCUL — quarterly report dated 2025-06-30
Total revenue: 13459000
Gross profit: 11515000
Operating income: -67641000
Net income: -67814000
Capital expenditures: 1115000
Operating cash flow: -55238000
Depreciation & amortization: 1026000
Net tangible assets: 305916000
Owner earnings: -67903000
Return on net tangible assets (%): -22.196616064540592
Buffett classification: The Gruesome
Stock price: 9.28
Shares outstanding: 218960358
Book value: 305916000
P/B ratio: 6.642189758757305
Market cap (USD): 2031952122.2399998
Debt to equity: 0.2515036807489638
Current ratio: 10.094686823041625
Quick ratio: 10.023898814376558
Interest coverage ratio: -22.42738726790451
COGS to revenue (%): 14.443866557693735
R&D to revenue (%): 379.5304257374248
SG&A to revenue (%): 208.5964781930307
Free cash flow (dilution-adjusted): -66161000
Buyback yield (%): 0
Retained earnings: -1022951000
Inventory turnover: 0.6396841066140178
Receivables turnover: 0.44255557016966984
Capitalized R&D asset: 79795190
ROCI (R&D-adjusted, %): -9.806010285857376
Rosenberg metric: 0.048510161700539005
FCF margin (%): -491.57441117467863
Revenue growth (%): 25.80856234810245
Rule of 40 score: -465.7658488265762
Financial ratios for OCUL — quarterly report dated 2025-09-30
Total revenue: 14544000
Gross profit: 12770000
Operating income: -68698000
Net income: -69418000
Capital expenditures: 5993000
Operating cash flow: -50725000
Depreciation & amortization: 1069000
Net tangible assets: 258229000
Owner earnings: -74342000
Return on net tangible assets (%): -28.789175499266157
Buffett classification: The Gruesome
Stock price: 11.69
Shares outstanding: 218960358
Book value: 258229000
P/B ratio: 9.912312656672952
Market cap (USD): 2559646585.02
Debt to equity: 0.2982159246250421
Current ratio: 7.85044833042561
Quick ratio: 7.779689211668763
Interest coverage ratio: -22.884077281812125
COGS to revenue (%): 12.197469746974697
R&D to revenue (%): 359.9972497249725
SG&A to revenue (%): 200.15126512651267
Free cash flow (dilution-adjusted): -68409000
Buyback yield (%): 0
Retained earnings: -1092369000
Inventory turnover: 0.5086009174311926
Receivables turnover: 0.47269890795631825
Capitalized R&D asset: 100725080
ROCI (R&D-adjusted, %): -14.082520298437876
Rosenberg metric: 0.024568822066913333
FCF margin (%): -470.3589108910891
Revenue growth (%): 8.061520172375362
Rule of 40 score: -462.29739071871376
Financial ratios for OCUL — annual report dated 2025-12-31
Total revenue: 51951000
Gross profit: 45377000
Operating income: -270017000
Net income: -265939000
Capital expenditures: 11880000
Operating cash flow: -204883000
Depreciation & amortization: 4323000
Net tangible assets: 654310000
Owner earnings: -273496000
Return on net tangible assets (%): -41.79914719322645
Buffett classification: The Gruesome
Stock price: 12.14
Shares outstanding: 218960358
Book value: 654310000
P/B ratio: 4.062567813605172
Market cap (USD): 2658178746.1200004
Debt to equity: 0.11763231495774175
Current ratio: 15.394421918671023
Quick ratio: 15.324272723694051
Interest coverage ratio: -22.815124630333756
COGS to revenue (%): 12.654231872341246
R&D to revenue (%): 379.38826971569364
SG&A to revenue (%): 227.71072741621913
Free cash flow (dilution-adjusted): -260077000
Buyback yield (%): 0
Retained earnings: -1157023000
Inventory turnover: 1.8445566778900113
Receivables turnover: 1.6949755301794454
Capitalized R&D asset: 302759600
ROCI (R&D-adjusted, %): -19.010784734919945
Rosenberg metric: -0.09965918439299565
FCF margin (%): -500.6198148255087
Revenue growth (%): -18.47370651099289
Rule of 40 score: -519.0935213365016
Financial ratios for OCUL — quarterly report dated 2025-12-31
Total revenue: 13250000
Gross profit: 11656000
Operating income: -69760000
Net income: -64654000
Capital expenditures: 2839000
Operating cash flow: -54249000
Depreciation & amortization: 1247000
Net tangible assets: 654310000
Owner earnings: -66246000
Return on net tangible assets (%): -10.124558695419603
Buffett classification: The Gruesome
Stock price: 12.14
Shares outstanding: 218960358
Book value: 654310000
P/B ratio: 4.062567813605172
Market cap (USD): 2658178746.1200004
Debt to equity: 0.11763231495774175
Current ratio: 15.394421918671023
Quick ratio: 15.324272723694051
Interest coverage ratio: -24.63276836158192
COGS to revenue (%): 12.030188679245283
R&D to revenue (%): 383.39622641509436
SG&A to revenue (%): 231.0641509433962
Free cash flow (dilution-adjusted): -68447000
Buyback yield (%): 0
Retained earnings: -1157023000
Inventory turnover: 0.44725028058361394
Receivables turnover: 0.43230016313213704
Capitalized R&D asset: 102736590
ROCI (R&D-adjusted, %): -8.183025059698828
Rosenberg metric: -0.02127659574468085
FCF margin (%): -516.5811320754717
Revenue growth (%): -8.897139713971397
Rule of 40 score: -525.478271789443
Financial ratios for OGN — annual report dated 2021-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 25.25
Shares outstanding: 262609433
Market cap (USD): 6630888183.25
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for OGN — annual report dated 2022-12-31
Total revenue: 6174000000
Gross profit: 3880000000
Operating income: 1705000000
Net income: 917000000
Capital expenditures: 7000000
Operating cash flow: 858000000
Depreciation & amortization: 212000000
Net tangible assets: -6144000000
Owner earnings: 1122000000
Return on net tangible assets (%): -18.26171875
Capex to operating income (%): 0.41055718475073316
Buffett classification: The Great
Stock price: 24.02
P/E ratio: 6.878820698647765
Shares outstanding: 262609433
Book value: -892000000
Market cap (USD): 6307878580.66
Debt to equity: -9.992152466367713
Current ratio: 1.564888535031847
Quick ratio: 1.1656050955414012
Effective tax rate (%): 18.270944741532976
Interest coverage ratio: 4.040284360189573
COGS to revenue (%): 37.155814706835116
R&D to revenue (%): 7.628765792031097
SG&A to revenue (%): 27.59961127308066
Free cash flow (dilution-adjusted): 356000000
Buyback yield (%): 0
Retained earnings: -331000000
Inventory turnover: 2.2871385842472582
Receivables turnover: 4.185762711864407
Capitalized R&D asset: 471000000
ROCI (R&D-adjusted, %): 22.64976441552614
FCF margin (%): 5.766115970197603
Rule of 40 score: 5.766115970197603
Financial ratios for OGN — annual report dated 2023-12-31
Total revenue: 6263000000
Gross profit: 3748000000
Operating income: 1327000000
Net income: 1023000000
Capital expenditures: 1000000
Operating cash flow: 799000000
Depreciation & amortization: 236000000
Net tangible assets: -5206000000
Owner earnings: 1258000000
Return on net tangible assets (%): -24.16442566269689
Capex to operating income (%): 0.07535795026375283
Buffett classification: The Great
Stock price: 13.18
P/E ratio: 3.3833747086412513
Shares outstanding: 262609433
Book value: -70000000
Market cap (USD): 3461192326.94
Debt to equity: -125.14285714285714
Current ratio: 1.544893762851268
Quick ratio: 1.0942426319396847
Effective tax rate (%): -52.00594353640417
Interest coverage ratio: 2.5180265654648957
COGS to revenue (%): 40.15647453297142
R&D to revenue (%): 8.43046463356219
SG&A to revenue (%): 30.225131726009902
Free cash flow (dilution-adjusted): 437000000
Buyback yield (%): 0
Retained earnings: 443000000
Inventory turnover: 1.9125475285171103
Receivables turnover: 3.591169724770642
Capitalized R&D asset: 843570000
ROCI (R&D-adjusted, %): 15.245047613228536
Rosenberg metric: -0.2802547770700637
FCF margin (%): 6.97748682739901
Revenue growth (%): 1.4415289925494008
Rule of 40 score: 8.41901581994841
Financial ratios for OGN — quarterly report dated 2024-09-30
Capital expenditures: 1000000
Buffett classification: The Gruesome
Stock price: 18.25
Shares outstanding: 262609433
Market cap (USD): 4792622152.25
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for OGN — annual report dated 2024-12-31
Total revenue: 6403000000
Gross profit: 3715000000
Operating income: 1486000000
Net income: 864000000
Capital expenditures: 4000000
Operating cash flow: 939000000
Depreciation & amortization: 277000000
Net tangible assets: -5622000000
Owner earnings: 1137000000
Return on net tangible assets (%): -20.22411953041622
Capex to operating income (%): 0.2691790040376851
Buffett classification: The Great
Stock price: 14.49
P/E ratio: 4.4041790326041665
Shares outstanding: 262609433
Book value: 472000000
P/B ratio: 8.061887042733051
Market cap (USD): 3805210684.17
Debt to equity: 18.8135593220339
Current ratio: 1.5997056659308315
Quick ratio: 1.1136865342163356
Effective tax rate (%): -7.063197026022305
Interest coverage ratio: 2.8576923076923078
COGS to revenue (%): 41.98032172419178
R&D to revenue (%): 7.324691550835547
SG&A to revenue (%): 27.48711541464938
Free cash flow (dilution-adjusted): 483000000
Buyback yield (%): 0
Retained earnings: 1010000000
Inventory turnover: 2.0348221044663135
Receivables turnover: 4.715022091310751
Capitalized R&D asset: 978190000
ROCI (R&D-adjusted, %): 12.900643917289182
Rosenberg metric: -0.0625
FCF margin (%): 7.543339059815711
Revenue growth (%): 2.235350471020278
Rule of 40 score: 9.778689530835988
Financial ratios for OGN — quarterly report dated 2024-12-31
Capital expenditures: 2000000
Buffett classification: The Gruesome
Stock price: 14.49
Shares outstanding: 262609433
Market cap (USD): 3805210684.17
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for OGN — quarterly report dated 2025-03-31
Total revenue: 1513000000
Gross profit: 841000000
Operating income: 325000000
Net income: 87000000
Capital expenditures: 97000000
Operating cash flow: 75000000
Depreciation & amortization: 84000000
Net tangible assets: -5555000000
Owner earnings: 74000000
Return on net tangible assets (%): -1.332133213321332
Capex to operating income (%): 29.846153846153843
Buffett classification: The Good
Stock price: 14.73
P/E ratio: 11.115623414051724
Shares outstanding: 262609433
Book value: 542000000
P/B ratio: 7.136968538911439
Market cap (USD): 3868236948.09
Debt to equity: 16.523985239852397
Current ratio: 1.67151051625239
Quick ratio: 1.1506692160611856
Effective tax rate (%): 13.861386138613863
Interest coverage ratio: 2.620967741935484
COGS to revenue (%): 44.41506939854594
R&D to revenue (%): 6.345009914077991
SG&A to revenue (%): 27.75941837409121
Free cash flow (dilution-adjusted): -46000000
Buyback yield (%): 0
Retained earnings: 1026000000
Inventory turnover: 0.4933920704845815
Receivables turnover: 1.0384351407000687
Capitalized R&D asset: 96000000
ROCI (R&D-adjusted, %): 3.6570461596314754
FCF margin (%): -3.040317250495704
Rule of 40 score: -3.040317250495704